UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 155 filers reported holding UNIQURE NV in Q1 2021. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,318,838 | +50.0% | 643,642 | +156.1% | 0.05% | +31.6% |
| Q2 2023 | $2,879,646 | -0.3% | 251,278 | +75.2% | 0.04% | -5.0% |
| Q1 2023 | $2,889,083 | +392.2% | 143,450 | +682.4% | 0.04% | +700.0% |
| Q3 2021 | $587,000 | -81.2% | 18,334 | -81.9% | 0.01% | -82.1% |
| Q2 2021 | $3,117,000 | +25.3% | 101,207 | +37.0% | 0.03% | 0.0% |
| Q1 2021 | $2,488,000 | +585.4% | 73,851 | +817.4% | 0.03% | +133.3% |
| Q2 2020 | $363,000 | -19.2% | 8,050 | +40.1% | 0.01% | -7.7% |
| Q2 2019 | $449,000 | – | 5,746 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
| Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
| Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
| Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
| 683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
| Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
| Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
| Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
| Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
| Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |